Port Capital’s Amgen AMGN Stock Holding History

Port Capital’s Portfolio AMGN Stock Details AMGN Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2019 Q1	–	Sell	-1,145	Closed	-$223K	–	127
2018 Q4	$223K	Buy	1,145 +2	+0.2%	+$390	0.03%	120
2018 Q3	$237K	Buy	+1,143	New	+$225K	0.03%	144

Other funds holding AMGN

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Primecap Management Pasadena, California $127B AUM 44.11% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return

Capital International Investors Los Angeles, California $427B AUM 29.17% 1-Year Est. Return

Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return

Port Capital's AMGN Position: Q1 2019 in Review

Port Capital sold out of Amgen (AMGN) in Q1 2019, closing a stake of 1,145 shares — an estimated $223K sold.

Port Capital first reported a position in AMGN in Q3 2018 and held it in 2 quarters. The position peaked at $237K in Q3 2018. 1,887 funds tracked by Wall St. Rank hold AMGN as of Q1 2019.

Port Capital reported no remaining Amgen position as of Q1 2019 after selling out during the quarter.
Port Capital sold 1,145 Amgen shares in Q1 2019, an estimated $223K.
Port Capital first reported a position in Amgen in Q3 2018 and held it in 2 quarters.
Port Capital's Amgen position peaked at $237K in Q3 2018.
1,887 funds tracked by Wall St. Rank held Amgen as of Q1 2019.

Based on Port Capital's 13F filing for Q1 2019, filed 15 May 2019.